Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Social isolation emerges as a key, independent risk factor for cognitive decline

17

Dec 2025

Social isolation emerges as a key, independent risk factor for cognitive decline

Using longitudinal data from the US Health and Retirement Study, this study applied causal inference modeling to disentangle the independent and joint effects of social isolation and loneliness on later-life cognitive function. It shows that reducing social isolation is associated with modest but meaningful protection against cognitive decline, with loneliness mediating only a small proportion of this effect.

AI analysis of chest X-rays may reveal early signs of aging

17

Dec 2025

AI analysis of chest X-rays may reveal early signs of aging

Artificial intelligence may be able to reveal how fast your body is aging by analyzing a chest X-ray, according to a new study published in The Journals of Gerontology. Researchers found that a deep learning model was able to detect subtle, age-related changes in the heart, lungs, and overall health more effectively than leading DNA-based "epigenetic clocks."

ECG-based AI model doubles early liver disease diagnoses

17

Dec 2025

ECG-based AI model doubles early liver disease diagnoses

As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease and resulting liver scarring or cirrhosis also are rising. Patients often are diagnosed based on symptoms, such as gastrointestinal bleeding, fluid retention or jaundice, which happen when liver disease has progressed to a late stage.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.